PLoS Neglected Tropical Diseases (Jan 2015)

Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi.

  • Luísa M D Magalhães,
  • Agostinho Viana,
  • Egler Chiari,
  • Lúcia M C Galvão,
  • Kenneth J Gollob,
  • Walderez O Dutra

DOI
https://doi.org/10.1371/journal.pntd.0003816
Journal volume & issue
Vol. 9, no. 7
p. e0003816

Abstract

Read online

BACKGROUND:Trypanosoma cruzi strains are currently classified into six discrete typing units (DTUs) named TcI to VI. It is known that these DTUs have different geographical distribution, as well as biological features. TcI and TcII are major DTUs found in patients from northern and southern Latin America, respectively. Our hypothesis is that upon infection of human peripheral blood cells, Y strain (Tc II) and Col cl1.7 (Tc I), cause distinct immunological changes, which might influence the clinical course of Chagas disease. METHODOLOGY/PRINCIPAL FINDINGS:We evaluated the infectivity of CFSE-stained trypomastigotes of Col cl1.7 and Y strain in human monocytes for 15 and 72 hours, and determined the immunological profile of lymphocytes and monocytes exposed to the different isolates using multiparameter flow cytometry. Our results showed a similar percentage and intensity of monocyte infection by Y and Col cl1.7. We also observed an increased expression of CD80 and CD86 by monocytes infected with Col cl1.7, but not Y strain. IL-10 was significantly higher in monocytes infected with Col cl1.7, as compared to Y strain. Moreover, infection with Col cl1.7, but not Y strain, led to an increased expression of IL-17 by CD8+ T cells. On the other hand, we observed a positive correlation between the expression of TNF-alpha and granzyme A only after infection with Y strain. CONCLUSION/SIGNIFICANCE:Our study shows that while Col cl1.7 induces higher monocyte activation and, at the same time, production of IL-10, infection with Y strain leads to a lower monocyte activation but higher inflammatory profile. These results show that TcI and TcII have a distinct immunological impact on human cells during early infection, which might influence disease progression.